Gastrointestinal Stents Market
Gastrointestinal Stents Market Size, Share & Industry Analysis, By Product Type (Esophageal Stents, Duodenal Stents, Colonic Stents, Biliary Stents), By Material (Metal Stents, Plastic Stents), By Application (Gastrointestinal Cancers, Gastrointestinal Obstruction, Inflammatory Bowel Disease), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
The Gastrointestinal Stents Market is projected to grow at a CAGR of 5.7% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031. Europe currently dominates the market, with key metrics indicating strong growth in minimally invasive gastrointestinal procedures and an aging population. The market is experiencing significant expansion due to increasing prevalence of gastrointestinal diseases, technological advancements in stent design, and growing preference for minimally invasive procedures.
Gastrointestinal Stents Market Dynamics:
Market Trend: Rising adoption of self-expanding metal stents (SEMS) drives market growth
The gastrointestinal stents market is witnessing a significant trend towards the adoption of self-expanding metal stents (SEMS). These stents are gaining popularity due to their ability to provide effective and long-lasting relief from various gastrointestinal obstructions. SEMS offer several advantages over traditional plastic stents, including better patency rates, reduced migration risk, and improved patient comfort. The versatility of SEMS in treating both malignant and benign strictures across different segments of the gastrointestinal tract has led to their increased use in clinical practice. This trend is further supported by ongoing innovations in stent materials and designs, which aim to enhance their performance and reduce complications. As healthcare providers increasingly recognize the benefits of SEMS, their adoption is expected to continue driving market growth in the coming years.
Market Driver: Increasing prevalence of gastrointestinal cancers fuels demand for stenting procedures
The gastrointestinal stents market is experiencing substantial growth driven by the rising incidence of gastrointestinal cancers worldwide. Colorectal cancer, esophageal cancer, and pancreatic cancer are among the leading causes of cancer-related deaths globally. According to recent epidemiological data, there were approximately 1.9 million new cases of colorectal cancer diagnosed worldwide in 2023, with a significant proportion of patients requiring palliative stenting procedures. Gastrointestinal stents play a crucial role in managing malignant obstructions, providing symptomatic relief, and improving quality of life for cancer patients. The growing adoption of stenting as a bridge to surgery or as a definitive palliative treatment has led to increased demand for advanced stenting technologies. This trend is further supported by the expanding elderly population, who are more susceptible to gastrointestinal cancers and related complications.
Market Restraint: Complications associated with stent placement and high procedural costs limit market expansion
Despite the overall positive outlook, the gastrointestinal stents market faces challenges related to complications associated with stent placement and the high costs of stenting procedures. Common complications include stent migration, tissue ingrowth, and perforation, which can lead to adverse patient outcomes and the need for repeat interventions. Recent clinical studies have reported complication rates ranging from 10% to 30% for various types of gastrointestinal stents, depending on the location and underlying condition. These complications not only affect patient safety but also increase healthcare costs and resource utilization. Additionally, the high costs associated with advanced stenting technologies and the specialized skills required for their placement can limit access to these procedures, particularly in resource-constrained healthcare settings. These factors collectively pose a significant restraint on market growth, especially in emerging economies.
Segment Overview:
Colorectal stents dominate the market, driven by rising incidence of colorectal cancer and bowel obstructions:
The colorectal stents segment currently holds the largest market share in the gastrointestinal stents market. This dominance is attributed to the high incidence of colorectal cancer and the increasing use of stents for managing acute malignant colonic obstruction. Colorectal stents offer an effective minimally invasive alternative to emergency surgery, reducing morbidity and improving patient outcomes.
Recent clinical data has shown that the use of colorectal stents as a bridge to surgery in patients with obstructing colorectal cancer can significantly reduce the need for emergency surgeries by up to 80%. This approach allows for better preoperative optimization of patients and increases the likelihood of successful primary anastomosis, leading to improved long-term outcomes.
The pharmaceutical and medical device industries have been major contributors to the growth of the colorectal stents segment. In 2023, a leading medical device company reported a 15% year-over-year increase in sales of its colorectal stent portfolio, reflecting the growing adoption of these devices in clinical practice. Ongoing research and development efforts are focused on improving stent designs to reduce complications such as migration and perforation, further driving market growth in this segment.
Regional Outlook:
Europe leads the gastrointestinal stents market, supported by advanced healthcare infrastructure and favorable reimbursement policies:
Europe currently dominates the gastrointestinal stents market, accounting for the largest market share. This leadership position is primarily due to the region's well-established healthcare infrastructure, high adoption rates of minimally invasive procedures, and favorable reimbursement policies for gastrointestinal stenting.
Germany, in particular, has been at the forefront of gastrointestinal stent utilization, with a strong emphasis on technological innovation and clinical research in this field. The country's robust medical device industry and close collaboration between academic institutions and manufacturers have led to the development of advanced stenting technologies tailored to specific gastrointestinal conditions.
Recent market analysis indicates that Europe accounted for approximately 35% of the global gastrointestinal stents market revenue in 2023. This dominance is expected to continue throughout the forecast period, supported by the region's aging population and the increasing prevalence of gastrointestinal diseases.
The United Kingdom has also emerged as a significant contributor to the regional market, with its National Health Service (NHS) actively promoting the use of gastrointestinal stents as a cost-effective alternative to surgical interventions in suitable cases. The country's comprehensive cancer care programs have further boosted the adoption of stenting procedures for managing malignant gastrointestinal obstructions.
Competitive Intelligence:
The gastrointestinal stents market is characterized by intense competition among key players, with a focus on product innovation and strategic collaborations. Leading companies are investing heavily in R&D to develop stents with improved designs, materials, and delivery systems. Market leaders have maintained their positions through a combination of broad product portfolios, strong distribution networks, and robust clinical evidence supporting their technologies.
Recent industry analysis reveals that the top five players collectively hold approximately 70% of the market share. These companies have been actively pursuing mergers and acquisitions to expand their product offerings and geographical presence. For instance, a major medical device company acquired a specialized stent manufacturer in 2023, gaining access to proprietary stent technologies and expanding its footprint in the gastrointestinal endoscopy space.
Collaborations with healthcare providers and academic institutions have become a key strategy for market players to drive innovation and clinical adoption. Several companies have established research partnerships aimed at developing next-generation stents, with a particular focus on reducing complications and improving long-term outcomes.
In terms of financial performance, the leading players have reported steady revenue growth, with an average year-over-year increase of 6-8% in their gastrointestinal stent segments. This growth is largely attributed to the rising demand for minimally invasive treatment options and the expansion of endoscopic services in emerging markets.
Analyst Opinion:
The gastrointestinal stents market is poised for significant growth in the coming years, driven by a convergence of technological advancements and evolving clinical practices. The increasing preference for minimally invasive procedures and the growing body of evidence supporting the efficacy of stenting in various gastrointestinal conditions are expected to be major catalysts for market expansion.
One of the most promising trends to watch is the development of bioabsorbable stents. These innovative devices offer the potential to provide temporary mechanical support while eliminating the need for stent removal procedures. As research in this area progresses, bioabsorbable stents could revolutionize the management of benign gastrointestinal strictures and expand the indications for stenting.
Another area of focus is the integration of drug-eluting technologies in gastrointestinal stents. This approach has the potential to address challenges such as tissue ingrowth and restenosis, which are common complications of current stenting procedures. Companies that can successfully develop and commercialize drug-eluting gastrointestinal stents are likely to gain a significant competitive edge in the market.
Major Players:
- Boston Scientific Corporation
- Cook Medical
- Olympus Corporation
- ELLA-CS, s.r.o.
- Merit Medical Systems, Inc.
- Taewoong Medical Co., Ltd.
- M.I. Tech Co., Ltd.
- CONMED Corporation
- Becton, Dickinson and Company
- W. L. Gore & Associates, Inc.
Key Developments:
- April 2024: Boston Scientific Corporation received FDA clearance for its new fully covered self-expanding metal stent designed specifically for treating benign biliary strictures.
- February 2024: Cook Medical announced the launch of its next-generation esophageal stent featuring an anti-migration design and improved radial force distribution.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Boston Scientific Corporation
5.2. Cook Medical
5.3. Olympus Corporation
5.4. ELLA-CS, s.r.o.
5.5. Merit Medical Systems, Inc.
5.6. Taewoong Medical Co., Ltd.
5.7. M.I. Tech Co., Ltd.
5.8. CONMED Corporation
5.9. Becton, Dickinson and Company
5.10. W. L. Gore & Associates, Inc. (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Rising adoption of self-expanding metal stents (SEMS) drives market growth
6.1.2. Increasing use of stents in palliative care for gastrointestinal cancers
6.1.3. Growing interest in biodegradable and drug-eluting stents
6.2. Market Drivers
6.2.1. Increasing prevalence of gastrointestinal cancers fuels demand for stenting procedures
6.2.2. Technological advancements in stent design and materials
6.2.3. Rising preference for minimally invasive gastrointestinal procedures
6.3. Market Restraints
6.3.1. Complications associated with stent placement and high procedural costs limit market expansion
6.3.2. Stringent regulatory approval processes for new stent technologies
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Esophageal Stents
7.2. Duodenal Stents
7.3. Colonic Stents
7.4. Biliary Stents
8. BY MATERIAL (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Metal Stents
8.1.1. Self-Expanding Metal Stents (SEMS)
8.1.2. Balloon-Expandable Metal Stents
8.2. Plastic Stents
9. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Gastrointestinal Cancers
9.2. Gastrointestinal Obstruction
9.3. Inflammatory Bowel Disease
10. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. Hospitals
10.2. Ambulatory Surgical Centers
10.3. Specialty Clinics
11. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
11.1. North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2. South America
11.2.1. Brazil
11.2.2. Argentina
11.2.3. Rest of South America
11.3. Europe
11.3.1. Germany
11.3.2. United Kingdom
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Russia
11.3.7. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia
11.4.5. South Korea
11.4.6. Rest of Asia-Pacific
11.5. Middle-East
11.5.1. UAE
11.5.2. Saudi Arabia
11.5.3. Turkey
11.5.4. Rest of Middle East
11.6. Africa
11.6.1. South Africa
11.6.2. Egypt
11.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
By Product Type:
-
Esophageal Stents
-
Duodenal Stents
-
Colonic Stents
-
Biliary Stents
By Material:
-
Metal Stents
-
Plastic Stents
By Application:
-
Gastrointestinal Cancers
-
Gastrointestinal Obstruction
-
Inflammatory Bowel Disease
By End User:
-
Hospitals
-
Ambulatory Surgical Centers
-
Specialty Clinics
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511